Literature DB >> 18421240

PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema.

N Miyamoto1, Y de Kozak, N Normand, Y Courtois, J C Jeanny, D Benezra, F Behar-Cohen.   

Abstract

VEGF is considered as an important factor in the pathogenesis of macular edema. VEGF induces the rupture of the blood retinal barrier and may also influence the retinal pigment epithelial (RPE) outer retinal barrier. The aim of this work was to analyze the influence of the VEGF receptor pathways in the modulation of the RPE barrier breakdown in vitro and in vivo. The ARPE19 human junctions in culture are modulated by VEGF through VEGFR-1 but not through VEGFR-2. PlGF-1, that is a pure agonist of VEGFR-1, is produced in ARPE-19 cells under hypoxic conditions and mimics VEGF effects on the external retinal barrier as measured by TER and inulin flux. In vivo, the intravitreous injection of PlGF-1 induces a rupture of the external retinal barrier together with a retinal edema. This effect is reversible within 4 days. VEGF-E, that is a pure agonist of VEGFR-2, does not induce any acute effect on the RPE barrier. These results demonstrate that PlGF-1 can reproduce alterations of the RPE barrier occurring during diabetic retinopathy. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421240     DOI: 10.1159/000119877

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  11 in total

1.  Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.

Authors:  Samy Omri; Francine Behar-Cohen; Yvonne de Kozak; Florian Sennlaub; Lourena Mafra Verissimo; Laurent Jonet; Michèle Savoldelli; Boubaker Omri; Patricia Crisanti
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

2.  Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.

Authors:  Shaomin Peng; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

3.  Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes.

Authors:  Nicolas Rocher; Francine Behar-Cohen; Jean-Antoine C Pournaras; Marie-Christine Naud; Jean-Claude Jeanny; Laurent Jonet; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2011-01-11       Impact factor: 2.367

4.  Aflibercept versus ranibizumab for treating persistent diabetic macular oedema.

Authors:  Kristof R O A Vandekerckhove
Journal:  Int Ophthalmol       Date:  2015-05-20       Impact factor: 2.031

5.  Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema.

Authors:  Cristina Hernández; Marta Garcia-Ramírez; Rafael Simó
Journal:  Diabetes Care       Date:  2013-04-25       Impact factor: 19.112

6.  PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy.

Authors:  Samy Omri; Francine Behar-Cohen; Pierre-Raphaël Rothschild; Emmanuelle Gélizé; Laurent Jonet; Jean Claude Jeanny; Boubaker Omri; Patricia Crisanti
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

Review 7.  Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.

Authors:  Quan Dong Nguyen; Sandro De Falco; Francine Behar-Cohen; Wai-Ching Lam; Xuri Li; Nadine Reichhart; Federico Ricci; Jennifer Pluim; William W Li
Journal:  Acta Ophthalmol       Date:  2016-11-22       Impact factor: 3.761

8.  Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis.

Authors:  Hyung-Ju Cho; Chang-Hoon Kim
Journal:  BMB Rep       Date:  2018-02       Impact factor: 4.778

9.  Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.

Authors:  Carsten Balser; Anne Wolf; Marc Herb; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2019-02-07       Impact factor: 8.322

Review 10.  Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.

Authors:  Hidetaka Noma; Kanako Yasuda; Masahiko Shimura
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.